Cramer’s Lightning Round: Merck is a buy
- It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Cassava Sciences: "They do have an Alzheimer's trial, but Lilly has an Alzheimer's formulation that is very good. And Lilly does have the edge on everybody else."
Mobileye Global: "...I think it's just too hard to tell, I'm going to stay away from it."
Get top local stories in Philly delivered to you every morning. >Sign up for NBC Philadelphia's News Headlines newsletter.
Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.
Disclaimer
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Money Report
Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com
Also on CNBC
Copyright CNBC
